Poster Abstract Session:
222. Antimicrobial Stewardship: Potpourri
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID

Prevalence of Antimicrobial Use in U.S. Hospital Patients, 2011 vs. 2015
Shelley S. Magill, MD, PhD; Erin O'Leary, MPH; Susan M. Ray, MD, FIDSA; Susan Morabit, MSN, RN, PHCNS-BC, CIC; Lewis Perry, DrPH, MPH, RN; Marion A. Kainer, MBBS, MPH; Raphaelle H. Beard, MPH; Wendy Bamberg, MD; Helen L. Johnston, MPH; Ruth Lynfield, MD, FIDSA; Jean Rainbow, RN, MPH; Linn Warnke, RN, MPH; Joelle Nadle, MPH; Deborah L. Thompson, MD, MSPH; Marla M. Sievers, MPH; Shamima Sharmin, MBBS, MSc, MPH; Emily B. Hancock, MS; Rebecca Pierce, PhD, MS, BSN; Alexia Y. Zhang, MPH; Meghan Maloney, MPH; Lucy E. Wilson, MD, ScM; Nicolai Buhr, MPH; Katherine Richards, MPH; Ghinwa Dumyati, MD, FSHEA; Jonathan R. Edwards, MStat
Small State, Big Collaboration: Creation of First New Hampshire Statewide Antibiogram Guides Stewardship Efforts
Hannah Leeman, BA; Benjamin Chan, MD, MPH; Katrina Hansen, MPH; Elizabeth Talbot, MD; Carly Zimmermann, MPH, MLS (ASCP) cm; Michael Calderwood, MD, MPH; Apara Dave, MD; Paul Santos, PharmD
National Healthcare Safety Network’s Electronic Antimicrobial Use and Resistance Surveillance — first cohort of hospital reporters, 2011–2017
Hsiu Wu, MD; Amy Webb, MPH; Erin O'Leary, MPH; Lindsey Weiner, MPH; Melinda Neuhauser, PharmD, MPH; Katharina Van Santen, MSPH; Liang Zhou, MStat; Jonathan R. Edwards, MStat; Daniel Pollock, MD
The Role of Infection Preventionists in Antimicrobial Stewardship Programs in Acute Care Hospitals
Monika Pogorzelska-Maziarz, PhD, MPH; Mary Lou Manning, PhD, CRNP, CIC, FAAN
  • ASP Poster.pdf (369.2 kB)
  • Antibiotic prescribing before and after an FDA boxed warning on fluoroquinolones in 2016
    Zachary Willis, MD, MPH; Stacie Dusetzina, PhD; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Nicholas Pajewski, PhD; Alan Kinlaw, PhD
  • FDA FQ Poster 9.27.18.pdf (1.2 MB)
  • Implementation of the National Healthcare Safety Network’s (NHSN) Antimicrobial Use Option in the US Veterans Affairs (VA) Medical Facilities
    Julia Lewis, DO; Stacey Slager, MS; Jeremy Barraza, BS; Gary Roselle, MD, FIDSA; Jeanmarie Mayer, MD; Makoto Jones, MD, MS
    Adverse Outcomes Associated with Potentially Inappropriate Antibiotic Use in Heart Failure Admissions
    Jason Frisbee, DO, PharmD, BCPS; Mark Rasnake, MD; R. Eric Heidel, PhD
  • IDSA poster-converted PDF.pdf (220.7 kB)
  • A Regional Collaboration to Share Antimicrobial Stewardship Resources in Three Geographically Related Veterans Affairs Medical Centers
    Ann Laake, MD; Jacqueline Bork, MD; Rohini Dave, PharmD; Ayne Adenew, PharmD; Heather Seitzinger, PharmD; Matt Zuzick, PharmD; James Chang, PharmD; Angelike P. Liappis, MD, FIDSA
    Successful Use of Telemedicine versus On-site Infectious Diseases Consultation After Implementation of a System-wide Antimicrobial Stewardship-led Staphylococcus aureus Bacteremia Care Bundle
    Jacqueline Isip, PharmD; Leigh Ann Medaris, MD; Lewis McCurdy, MD; Marc Kowalkowski, PhD; Kristin Fischer, MM; Jennifer Onsrud, PharmD; Lisa Davidson, MD
    Excess Antibiotic Duration in Patients Hospitalized for Pneumonia: A Multi-Hospital Cohort Study
    Valerie Vaughn, MD, MSc; Scott Flanders, MD; Vineet Chopra, MD, MSc; Anna Conlon, PhD; Anurag Malani, MD, FIDSA; Rama Thyagarajan, MD; Lama Hsaiky, PharmD; Tejal Gandhi, MD
    Identifying time periods of high and low vancomycin use
    Jiajun Liu, PharmD; Nicholas Mercuro, PharmD; Susan Davis, PharmD; Paul R. Yarnold, Phd; Twisha S. Patel, PharmD, BCPS; Lindsay Petty, MD; Gwendolyn Pais, PhD; Keith Kaye, MD, MPH; Marc H. Scheetz, PharmD, MSc, BCPS AQ-ID
  • AbxOutbreak_IDWeek_FINAL.pdf (926.7 kB)
  • Antimicrobial utilization variability among training services at an academic medical center
    Lucas T Schulz, PharmD, BCPS (AQ-ID); Edward Lalik, MD; Ann Sheehy, MD; Barry Fox, MD, FIDSA, FSHEA
    Next Steps in Predicting Anti-MRSA Antibiotic Prescribing
    Haley K. Holmer, MPH; Amy Pakyz, PharmD, MS, PhD; Gregory B. Tallman, PharmD; Miriam R. Elman, MPH, MS; Samuel Hohmann, PhD; Rochelle Fu, PhD; Kristi Kuper, PharmD, BCPS; Jessina C. McGregor, PhD
  • Holmer_IDWeek2018_final.pdf (127.7 kB)
  • Adherence to Practice Guidelines for Treating Diabetic Foot Infections: An Opportunity for Syndromic Stewardship
    Randy McCreery, MD; Scott Bergman, PharmD, FIDSA, FCCP, BCPS; Trevor Vanschooneveld, MD
    How many different antimicrobial regimens are there and which are emerging and declining?
    Makoto Jones, MD, MS; Barbara Jones, MD; Vanessa Stevens, PhD; Julia Lewis, DO; Kelly Peterson, MS; Karl Madaras-Kelly, PharmD, MPH; Christopher Graber, MD, MPH, FIDSA; Matthew B. Goetz, MD; Peter Glassman, MBBS, MSc
    Patient- and Hospital-Level Factors and Outcomes Associated with Treatment of Asymptomatic Bacteriuria in Hospitalized Patients: A Multi-Hospital Cohort Study
    Lindsay Petty, M.D.; Anna Conlon, PhD; Valerie Vaughn, MD, MSc; Daniel Nielsen, MS; Keith Kaye, MD, MPH; Anurag Malani, MD, FIDSA; Rama Thyagarajan, MD; Danielle Osterholzer, MD; Gregory Eschenauer, PharmD, BCPS; Scott Flanders, M.D.; Tejal N. Gandhi, MD
    Discrepant Susceptibilities have Minimal Impact on Antibiotic Prescribing for Patients with Two or More Blood Cultures Positive for Coagulase-Negative Staphylococci
    Jessica Smith, PharmD; Elizabeth Palavecino, MD; James Beardsley, PharmD; James Johnson, PharmD; Christopher Ohl, MD, FIDSA; Vera Luther, MD; John Williamson, PharmD
    Expanding Kentucky’s ‘One and Done’ Tradition: Lipoglycopeptide Administration in the Emergency Department at a Tertiary, Academic Medical Center
    Donna R. Burgess, RPh; Garrett Hile, PharmD; Jeffrey Reynolds, MBA; Sarah Cotner, PharmD, BCPS; Regan Baum, PharmD; Abby M. Bailey, PharmD, BCPS; Thein Myint, MBBS; Katie L. Wallace, PharmD, BCPS
    A Point Prevalence Study of Antibiotic Utilization in 61 Geographically Diverse Acute Care Hospitals (2017)
    Kristi Kuper, PharmD, BCPS; Patrick Kinn, PharmD, MPH; Michael Postelnick, RPh BCPS AQ ID; Amanda Gibson, PharmD; Amy Pakyz, PharmD, MS, PhD; Lucas T Schulz, PharmD, BCPS (AQ-ID)
    Empiric Pseudomonal Monotherapy versus Combination Therapy for Community-Onset Pneumonia in Older Adults
    Obiageri Obodozie-Ofoegbu, BPharm, MSc, PhD; Chengwen Teng, PharmD, MS; Eric M. Mortensen, MD, MSc; Christopher R. Frei, PharmD, MSc
  • Poster 1881_IDWeek 2018.pdf (826.3 kB)
  • Acute Kidney Injury in Patients with Pneumonia on Concomitant Anti-Methicillin Resistant Staphylococcus aureus and Anti-Pseudomonal Beta-Lactam Therapy
    Brian R. Raux, PharmD; J. Madison Hyer, MS; Tiffeny T. Smith, PharmD; John W. Gnann Jr., MD; Shawn H. MacVane, PharmD
  • AKI_in_PNA IDWeek2018 FINAL.pdf (367.7 kB)
  • Assessment of potential antimicrobial-related harms in hospitalized adults with common infections
    Nicholas J Mercuro, PharmD; Rachel Kenney, PharmD, BCPS (AQ-ID); Raghavendra Vemulapalli, MD; Mariam Costandi, MD; Charles T Makowski, PharmD; Berta Rezik, MD; Susan L Davis, PharmD
    Cost-Effectiveness of Ceftazidime-Avibactam Compared to Colistin for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia
    Maroun Sfeir, MD, MPH; Michael Satlin, MD, MS; David P. Calfee, MD, MS; Matthew S. Simon, MD, MS
  • CRE_CEA_ID_Week2018_Final-.pdf (390.9 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.